These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33081139)

  • 1. Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey.
    Bernstein L; Coughlin CR; Drumm M; Yannicelli S; Rohr F
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary practices in glutaric aciduria type 1 over 16 years.
    Gokmen-Ozel H; MacDonald A; Daly A; Ashmore C; Preece MA; Hendriksz C; Vijay S; Chakrapani A
    J Hum Nutr Diet; 2012 Dec; 25(6):514-9. PubMed ID: 22845646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
    Boy N; Haege G; Heringer J; Assmann B; Mühlhausen C; Ensenauer R; Maier EM; Lücke T; Hoffmann GF; Müller E; Burgard P; Kölker S
    J Inherit Metab Dis; 2013 May; 36(3):525-33. PubMed ID: 22971958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
    Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
    Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition support for glutaric acidemia type I.
    Yannicelli S; Rohr F; Warman ML
    J Am Diet Assoc; 1994 Feb; 94(2):183-8,191; quiz 189-90. PubMed ID: 8300996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of glutaric aciduria type I--revised recommendations.
    Kölker S; Christensen E; Leonard JV; Greenberg CR; Boneh A; Burlina AB; Burlina AP; Dixon M; Duran M; García Cazorla A; Goodman SI; Koeller DM; Kyllerman M; Mühlhausen C; Müller E; Okun JG; Wilcken B; Hoffmann GF; Burgard P
    J Inherit Metab Dis; 2011 Jun; 34(3):677-94. PubMed ID: 21431622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
    Prats Viñas J
    Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.
    Strauss KA; Brumbaugh J; Duffy A; Wardley B; Robinson D; Hendrickson C; Tortorelli S; Moser AB; Puffenberger EG; Rider NL; Morton DH
    Mol Genet Metab; 2011; 104(1-2):93-106. PubMed ID: 21820344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
    Boy N; Mühlhausen C; Maier EM; Heringer J; Assmann B; Burgard P; Dixon M; Fleissner S; Greenberg CR; Harting I; Hoffmann GF; Karall D; Koeller DM; Krawinkel MB; Okun JG; Opladen T; Posset R; Sahm K; Zschocke J; Kölker S;
    J Inherit Metab Dis; 2017 Jan; 40(1):75-101. PubMed ID: 27853989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
    Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance to clinical guidelines determines outcome in glutaric aciduria type I in the era of newborn screening.
    Höliner I; Simma B; Reiter A; Sass JO; Zschocke J; Huemer M
    Klin Padiatr; 2010; 222(1):35-7. PubMed ID: 20084589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
    Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrocephaly and dystonic cerebral palsy in a child with type I glutaric aciduria].
    Plöchl E; Christensen E; Colombo JP; Weiss-Wichert P; Wenger E
    Padiatr Padol; 1991; 26(2):97-101. PubMed ID: 1945471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey.
    Bozaci AE; Er E; Ünal AT; Taş İ; Ayaz E; Ozbek MN; Durmaz A; Aykut A; Kose M
    Mol Genet Metab Rep; 2023 Sep; 36():100979. PubMed ID: 37275239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.
    Harting I; Neumaier-Probst E; Seitz A; Maier EM; Assmann B; Baric I; Troncoso M; Mühlhausen C; Zschocke J; Boy NP; Hoffmann GF; Garbade SF; Kölker S
    Brain; 2009 Jul; 132(Pt 7):1764-82. PubMed ID: 19433437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of interventional and non-interventional variables on anthropometric long-term development in glutaric aciduria type 1: A national prospective multi-centre study.
    Märtner EMC; Maier EM; Mengler K; Thimm E; Schiergens KA; Marquardt T; Santer R; Weinhold N; Marquardt I; Das AM; Freisinger P; Grünert SC; Vossbeck J; Steinfeld R; Baumgartner MR; Beblo S; Dieckmann A; Näke A; Lindner M; Heringer-Seifert J; Lenz D; Hoffmann GF; Mühlhausen C; Ensenauer R; Garbade SF; Kölker S; Boy N
    J Inherit Metab Dis; 2021 May; 44(3):629-638. PubMed ID: 33274439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
    Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
    Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.